Hormonal changes at puberty may trigger disease activity, but DMTs reduced the risk, indicating more aggressive treatment may be warranted.

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

A young woman has taken to social media to bring awareness to Multiple sclerosis, often shortened to 'MS' after having been ...

Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a diversified, vertically integrated global healthcare ...

Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

Hutchinson Walk MS on Sunday, May 3, has been canceled as a community event. This means rather than walking outdoors, this year’s Walk MS is becoming a virtual event. All Walk MS events through June ...

Having multiple sclerosis (MS) was associated with higher rates of mental illness during the peripartum period than not ...

Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.

Neuraxpharm Ireland, part of Neuraxpharm Group, a leading European speciality pharmaceutical company focused on the treatment ...